<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hipertensión &#187; Dislipidemia</title>
	<atom:link href="https://temas.sld.cu/hipertension/tag/dislipidemia/feed/" rel="self" type="application/rss+xml" />
	<link>https://temas.sld.cu/hipertension</link>
	<description>Sitio web dedicado a la hipertensión en Cuba</description>
	<lastBuildDate>Fri, 06 Jun 2025 14:42:55 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia</title>
		<link>https://temas.sld.cu/hipertension/2013/07/01/effect-of-bezafibrate-on-office-home-and-ambulatory-blood-pressure-in-hypertensive-patients-with-dyslipidemia/</link>
		<comments>https://temas.sld.cu/hipertension/2013/07/01/effect-of-bezafibrate-on-office-home-and-ambulatory-blood-pressure-in-hypertensive-patients-with-dyslipidemia/#comments</comments>
		<pubDate>Mon, 01 Jul 2013 11:48:59 +0000</pubDate>
		<dc:creator><![CDATA[hipertension]]></dc:creator>
				<category><![CDATA[Propuestas del editor]]></category>
		<category><![CDATA[Bensofibratos]]></category>
		<category><![CDATA[Colesterol]]></category>
		<category><![CDATA[Dislipidemia]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/hta/?p=2746</guid>
		<description><![CDATA[Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia Por: Y Ohta, Y Kawano, Y Iwashima, S Hayashi, F Yoshihara y S Nakamura.  Journal of Human Hypertension (2013) 27, 417–420. It has been suggested that fibrates, lipid-lowering agents with a peroxisome proliferator-activated receptor-α agonistic property, lower blood pressure (BP) [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/hipertension/2013/07/01/effect-of-bezafibrate-on-office-home-and-ambulatory-blood-pressure-in-hypertensive-patients-with-dyslipidemia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
